PMID: 7547083Jan 1, 1994Paper

Semi-synthesis of polymyxin-B conjugated ovalbumin: evaluation of lipopolysaccharide binding avidity and neutralization of induced tnf-alpha synthesis

Biotherapy
C P CoyneV C Langston

Abstract

A method is described in these investigations for the semi-synthetic production of polymyxin-B conjugated ovalbumin in the form of polymyxin-B.Sulfo-SMCC.ovalbumin (PSO). The heterobifunctional "cross-linking" agent, Sulfo-SMCC was first reacted with polymyxin-B to produce a relatively pure reactive intermediate in the form of polymyxin-B.Sulfo-SMCC. Highly purified ovalbumin was then combined with the polymyxin-B.Sulfo-SMCC reactive intermediate and contaminants removed from the final PSO end product by exhaustive microdialysis. Purity of PSO was established with by high-performance cellulose acetate electrophoresis (HPCAE), and high-performance thin layer chromatography (HPTLC) analyses. Verification of polymyxin-B.Sulfo-SMCC.ovalbumin binding avidity for lipopolysaccharide (LPS) was determined by DotBLot analysis applying fluorescein isothiocyanate labeled E. coli (055:B5) LPS fractions (FITC-LPS). Efficacy of PSO to inhibit in vitro LPS-induced synthesis of tumor necrosis factor-alpha (TNF-alpha) was assessed with a tissue culture based biological assay system. In this context, semi-synthetic conjugates of PSO (0.349 microgram/ml) effectively inhibited Salmonella minnesota (RS) LPS (2.5 ng/ml well) induced TNF-alpha synthes...Continue Reading

References

Oct 1, 1976·Immunochemistry·D C Morrison, D M Jacobs
Oct 1, 1977·The Journal of Infectious Diseases·R M BannatyneW D Biggar
Feb 1, 1992·Archives of Surgery·P LeónJ M Daly
May 26, 1990·Lancet·A R ExleyS Stephens
Feb 1, 1990·Immunological Investigations·M K EskandariD G Remick
Apr 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·M BrockhausH Loetscher
Aug 1, 1990·The Journal of Experimental Medicine·F Porteu, C Nathan
May 1, 1990·Clinical Immunology and Immunopathology·Y Fong, S F Lowry
Mar 1, 1990·British Journal of Cancer·G Semenzato
Jun 7, 1990·The New England Journal of Medicine·T van der PollJ W ten Cate
Jul 1, 1990·American Journal of Respiratory Cell and Molecular Biology·K Schollmeier
Sep 30, 1988·Biochemical and Biophysical Research Communications·R M StrieterS L Kunkel
Mar 15, 1989·Biochemical and Biophysical Research Communications·U F SchadeD T Wolter
Jul 1, 1989·The Journal of Burn Care & Rehabilitation·A M MunsterR A Winchurch
Sep 1, 1989·Antimicrobial Agents and Chemotherapy·R L DannerJ E Parrillo
Dec 1, 1989·Archives of Surgery·L Sanchez-CantuN V Christou
Jan 6, 1989·Journal of Immunological Methods·A MeagerJ Woolley
Jun 1, 1989·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·B A SherryL L Moldawer
Jun 15, 1989·Biochemical and Biophysical Research Communications·D G RemickS L Kunkel
Nov 1, 1987·The Journal of Infectious Diseases·P M FlynnW K Hildner
Dec 16, 1987·Biochemical and Biophysical Research Communications·P SuffysW Fiers
Mar 1, 1988·The Journal of Infectious Diseases·J L ShenepD F Westenkirchner
Apr 1, 1986·Infection and Immunity·K M MinerH Zweerink
Oct 24, 1986·Science·K J TraceyJ D Albert
Apr 1, 1985·Archives of Disease in Childhood·M AdhikariD J Pudifin
Jan 1, 1985·Haematology and Blood Transfusion·S L Gaffin

❮ Previous
Next ❯

Citations

Jul 6, 2010·Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association·I-Chun Lin, Cheng-Deng Kuo
Aug 23, 2003·Infection and Immunity·Hirofumi ShimomuraKazuyoshi Kawahara

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.